Among 400+ spinal bone grafts on the market, spine surgeons can feel confident in choosing i-FACTOR Peptide Enhanced Bone Graft which is backed by Level 1 human clinical data from an IDE study published in Spine and Neurosurgery which showed high fusion rates and statistical superiority vs. autograft in overall clinical success.
One of only two Class III FDA-PMA approved spinal bone grafts, i-FACTOR is the leading evidence-based alternative and is powered by a first of its kind molecule called P-15: Osteogenic Cell Binding Peptide. i-FACTOR is free of many safety risks seen with other products such as ectopic bone formation and on average costs 30% less than other drug-device combination products.
Download the i-FACTOR Technical Overview Brochure
Download the ISASS Guidelines
Product Categories
Biomaterials
- Bone Graft Matrix
- Bone Substitute Material
- Peptide Enhanced Bone Graft
Fusion
- Anterior Cervical Discectomy and Fusion (ACDF)
- Spine Fusion
Implants
- Biomaterials
Spine Biologics
- Peptide Enhanced Bone Graft